Abdou ElSharawy

Abdou ElSharawy

Auto-generated profile, based on publicly available information

Abdou ElSharawy

Institute of Clinical Molecular Biology, Center of Molecular Sciences, University of Kiel, 24118 Kiel, Germany

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2012 in Aging Cell
Verified
Journal Article
Open access
PDF file
AEAbdou ElSharawy
Abdou ElSharawy
AKAndreas Keller
Andreas Keller
FFFriederike Flachsbart
Friederike Flachsbart
AWAnke Wendschlag
Anke Wendschlag
GJGunnar Jacobs
Gunnar Jacobs
ANAlmut Nebel
Almut Nebel
Summary: Little is known about the functions of miRNAs in human longevity. Here, we present the first genome‐wide miRNA study in long‐lived individuals (LLI) who are considered a model for healthy aging. Using a microarray with 863 miRNAs, we compared the expression profiles obtained from blood samples of 15 centenarians and nonagenarians (mean age 96.4 years) with those of 55 younger individuals (mean age 45.9 years). Eighty miRNAs showed aging‐associated expression changes, with 16 miRNAs being up‐regulated and 64 down‐regulated in the LLI relative to the younger probands. Seven of the eight selected aging‐related biomarkers were technically validated using quantitative RT‐PCR, confirming the microarray data. Three of the eight miRNAs were further investigated in independent samples of 15 LLI and 17 younger participants (mean age 101.5 and 36.9 years, respectively). Our screening confirmed previously published miRNAs of human aging, thus reflecting the utility of the applied approach. The hierarchical clustering analysis of the miRNA microarray expression data revealed a distinct separation between the LLI and the younger controls (P‐value < 10−5). The down‐regulated miRNAs appeared as a cluster and were more often reported in the context of diseases than the up‐regulated miRNAs. Moreover, many of the differentially regulated miRNAs are known to exhibit contrasting expression patterns in major age‐related diseases. Further in silico analyses showed enrichment of potential targets of the down‐regulated miRNAs in p53 and other cancer pathways. Altogether, synchronized miRNA–p53 activities could be involved in the prevention of tumorigenesis and the maintenance of genomic integrity during aging.

8 August 2007 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AFAndre Franke
Andre Franke
JHJochen Hampe
Jochen Hampe
PRPhilip Rosenstiel
Philip Rosenstiel
CBChristian Becker
Christian Becker
FWFlorian Wagner
Florian Wagner
SSStefan Schreiber
Stefan Schreiber
Crohn disease (CD), a sub-entity of inflammatory bowel disease (IBD), is a complex polygenic disorder. Although recent studies have successfully identified CD-associated genetic variants, these susceptibility loci explain only a fraction of the heritability of the disease. Here, we report on a multi-stage genome-wide scan of 393 German CD cases and 399 controls. Among the 116,161 single-nucleotide polymorphisms tested, an association with the known CD susceptibility gene NOD2, the 5q31 haplotype, and the recently reported CD locus at 5p13.1 was confirmed. In addition, SNP rs1793004 in the gene encoding nel-like 1 precursor (NELL1, chromosome 11p15.1) showed a consistent disease-association in independent German population- and family-based samples (942 cases, 1082 controls, 375 trios). Subsequent fine mapping and replication in an independent sample of 454 French/Canadian CD trios supported the authenticity of the NELL1 association. Further confirmation in a large German ulcerative colitis (UC) sample indicated that NELL1 is a ubiquitous IBD susceptibility locus (combined p<10−6; OR = 1.66, 95% CI: 1.30–2.11). The novel 5p13.1 locus was also replicated in the French/Canadian sample and in an independent UK CD patient panel (453 cases, 521 controls, combined p<10−6 for SNP rs1992660). Several associations were replicated in at least one independent sample, point to an involvement of ITGB6 (upstream), GRM8 (downstream), OR5V1 (downstream), PPP3R2 (downstream), NM_152575 (upstream) and HNF4G (intron).

14 October 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MHMatthias Hübenthal
Matthias Hübenthal
GHGeorg Hemmrich-Stanisak
Georg Hemmrich-Stanisak
FDFrauke Degenhardt
Frauke Degenhardt
SSSilke Szymczak
Silke Szymczak
ZDZhipei Du
Zhipei Du
AFAndre Franke
Andre Franke
The diagnosis of inflammatory bowel disease (IBD) still remains a clinical challenge and the most accurate diagnostic procedure is a combination of clinical tests including invasive endoscopy. In this study we evaluated whether systematic miRNA expression profiling, in conjunction with machine learning techniques, is suitable as a non-invasive test for the major IBD phenotypes (Crohn's disease (CD) and ulcerative colitis (UC)). Based on microarray technology, expression levels of 863 miRNAs were determined for whole blood samples from 40 CD and 36 UC patients and compared to data from 38 healthy controls (HC). To further discriminate between disease-specific and general inflammation we included miRNA expression data from other inflammatory diseases (inflammation controls (IC): 24 chronic obstructive pulmonary disease (COPD), 23 multiple sclerosis, 38 pancreatitis and 45 sarcoidosis cases) as well as 70 healthy controls from previous studies. Classification problems considering 2, 3 or 4 groups were solved using different types of penalized support vector machines (SVMs). The resulting models were assessed regarding sparsity and performance and a subset was selected for further investigation. Measured by the area under the ROC curve (AUC) the corresponding median holdout-validated accuracy was estimated as ranging from 0.75 to 1.00 (including IC) and 0.89 to 0.98 (excluding IC), respectively. In combination, the corresponding models provide tools for the distinction of CD and UC as well as CD, UC and HC with expected classification error rates of 3.1 and 3.3%, respectively. These results were obtained by incorporating not more than 16 distinct miRNAs. Validated target genes of these miRNAs have been previously described as being related to IBD. For others we observed significant enrichment for IBD susceptibility loci identified in earlier GWAS. These results suggest that the proposed miRNA signature is of relevance for the etiology of IBD. Its diagnostic value, however, should be further evaluated in large, independent, clinically well characterized cohorts.

7 December 2017 in Advanced Materials
Verified
Journal Article
Open access
PDF file
Mady ElbahriMady Elbahri
Mady Elbahri
MAMoheb Abdelaziz
Moheb Abdelaziz
Shahin HomaeigoharShahin Homaeigohar
Shahin Homaeigohar
AEAbdou Elsharawy
Abdou Elsharawy
MHMehdi Keshavarz Hedayati
Mehdi Keshavarz Hedayati
RARamzy Abdelaziz
Ramzy Abdelaziz
Plasmonic dipoles are famous for their strong absorptivity rather than their reflectivity. Here, the as‐yet unknown specular reflection and the Brewster effect of ultrafine plasmonic dipoles, metaparticles, are introduced and exploited as the basis of new design rules for advanced applications. A configuration of “Plasmonic metaparticles on a blackbody” is demonstrated and utilized for the design of a tailored perfect‐colored absorber and for visual detection of environmental dielectrics that is not readily done by extinction plasmonics. Moreover, the Plasmonic Brewster Wavelength (PBW) effect is introduced as a new platform for the naked‐eye and bulk biodetection of analytes. The technique operates based on slight changes of molecular polarizability which is not detectable via conventional plasmon resonance techniques. As a specific highlight, the clinical applicability of the PBW method is demonstrated while addressing the transduction plasmonic techniques' challenge in detection of bulk refractive index changes of the healthy and diseased human serum exosomes. Finally, the sputtering‐based fabrication method used here is simple, inexpensive, and scalable, and does not require the sophisticated patterning approach of lithography or precise alignment of light coupling for the biodetection.

25 August 2006 in Human Mutation
Verified
Journal Article
Closed access
PDF file
AEAbdou ElSharawy
Abdou ElSharawy
CMCarl Manaster
Carl Manaster
MTMarkus Teuber
Markus Teuber
PRPhilip Rosenstiel
Philip Rosenstiel
RKRuta Kwiatkowski
Ruta Kwiatkowski
JHJochen Hampe
Jochen Hampe
Functional annotation of SNPs (as generated by HapMap (http://www.hapmap.org) for instance) is a major challenge. SNPs that lead to single amino acid substitutions, stop codons, or frameshift mutations can be readily interpreted, but these represent only a fraction of known SNPs. Many SNPs are located in sequences of splicing relevance—the canonical splice site consensus sequences, exonic and intronic splice enhancers or silencers (exonic splice enhancer [ESE], intronic splice enhancer [ISE], exonic splicing silencer [ESS], and intronic splicing silencer [ISS]), and others. We propose using sets of matching DNA and complementary DNA (cDNA) as a screening method to investigate the potential splice effects of SNPs in RT‐PCR experiments with tissue material from genotyped sources. We have developed a software solution (SNPSplicer; http://www.ikmb.uni‐kiel.de/snpsplicer) that aids in the rapid interpretation of such screening experiments. The utility of the approach is illustrated for SNPs affecting the donor splice sites (rs2076530:A>G, rs3816989:G>A) leading to the use of a cryptic splice site and exon skipping, respectively, and an exonic splice enhancer SNP (rs2274987:C/T), leading to inclusion of a new exon. We anticipate that this methodology may help in the functional annotation of SNPs in a more high‐throughput fashion. Hum Mutat 27(11), 1129–1134, 2006.

20 September 2012 in BMC Genomics
Verified
Journal Article
Open access
PDF file
AEAbdou ElSharawy
Abdou ElSharawy
JWJason Warner
Jason Warner
JOJeff Olson
Jeff Olson
MFMichael Forster
Michael Forster
MSMarkus B Schilhabel
Markus B Schilhabel
AFAndre Franke
Andre Franke
Background: Many hypothesis-driven genetic studies require the ability to comprehensively and efficiently target specific regions of the genome to detect sequence variations. Often, sample availability is limited requiring the use of whole genome amplification (WGA). We evaluated a high-throughput microdroplet-based PCR approach in combination with next generation sequencing (NGS) to target 384 discrete exons from 373 genes involved in cancer. In our evaluation, we compared the performance of six non-amplified gDNA samples from two HapMap family trios. Three of these samples were also preamplified by WGA and evaluated. We tested sample pooling or multiplexing strategies at different stages of the tested targeted NGS (T-NGS) workflow. Results: The results demonstrated comparable sequence performance between non-amplified and preamplified samples and between different indexing strategies [sequence specificity of 66.0% ± 3.4%, uniformity (coverage at 0.2× of the mean) of 85.6% ± 0.6%]. The average genotype concordance maintained across all the samples was 99.5% ± 0.4%, regardless of sample type or pooling strategy. We did not detect any errors in the Mendelian patterns of inheritance of genotypes between the parents and offspring within each trio. We also demonstrated the ability to detect minor allele frequencies within the pooled samples that conform to predicted models. Conclusion: Our described PCR-based sample multiplex approach and the ability to use WGA material for NGS may enable researchers to perform deep resequencing studies and explore variants at very low frequencies and cost.